FDA Approves New Device For Prevention Of Recurrent Strokes In Certain Patients

The U.S.Food and Drug Administration today approved the Amplatzer PFO Occluder device. The PFO Occluder reduces the risk of a stroke in patients who previously had a stroke believed to be caused by a blood clot that passed through a small hole in the heart, called a patent foramen ovale (PFO), and then traveled to the brain. "The Amplatzer PFO Occluder provides a non-surgical method for doctors to close a PFO," said Bram Zuckerman, M.D., director of the Division of Cardiovascular Devices in the ...